全文获取类型
收费全文 | 690篇 |
免费 | 73篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 71篇 |
妇产科学 | 9篇 |
基础医学 | 59篇 |
口腔科学 | 28篇 |
临床医学 | 74篇 |
内科学 | 146篇 |
皮肤病学 | 8篇 |
神经病学 | 20篇 |
特种医学 | 104篇 |
外科学 | 73篇 |
综合类 | 68篇 |
预防医学 | 33篇 |
眼科学 | 6篇 |
药学 | 19篇 |
中国医学 | 4篇 |
肿瘤学 | 45篇 |
出版年
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 9篇 |
2019年 | 6篇 |
2018年 | 16篇 |
2017年 | 15篇 |
2016年 | 12篇 |
2015年 | 20篇 |
2014年 | 19篇 |
2013年 | 28篇 |
2012年 | 28篇 |
2011年 | 30篇 |
2010年 | 45篇 |
2009年 | 29篇 |
2008年 | 20篇 |
2007年 | 22篇 |
2006年 | 30篇 |
2005年 | 15篇 |
2004年 | 10篇 |
2003年 | 10篇 |
2002年 | 8篇 |
2001年 | 6篇 |
2000年 | 13篇 |
1999年 | 7篇 |
1998年 | 15篇 |
1997年 | 17篇 |
1996年 | 17篇 |
1995年 | 15篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1990年 | 6篇 |
1989年 | 11篇 |
1988年 | 8篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 21篇 |
1984年 | 14篇 |
1983年 | 19篇 |
1982年 | 14篇 |
1981年 | 18篇 |
1980年 | 12篇 |
1979年 | 20篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1976年 | 14篇 |
1975年 | 12篇 |
1974年 | 7篇 |
1972年 | 6篇 |
1971年 | 7篇 |
1968年 | 5篇 |
排序方式: 共有769条查询结果,搜索用时 0 毫秒
11.
该研究以山东万杰医学院为例,针对目前招生规模越来越大,生源质量不断下滑,大面积学生逃学、厌学、考试成绩不及格的严峻现实,提出有关教学方法、教学内容和考核方式的教学三项改革,这三项改革举措顺应了当前高校教育(特别是民办高校教育)形势的发展趋势。通过改革实践,已初见成效,进一步验证了只有坚定不移地搞好教学三项改革,才能保证和提高教学质量,从而使广大学生及其家长的利益得到充分保障;也只有大张旗鼓地继续搞好教学三项改革,学校才有生存和可持续发展的空间。 相似文献
12.
Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study 总被引:7,自引:0,他引:7
Baehner F Kampmann C Whybra C Miebach E Wiethoff CM Beck M 《Journal of inherited metabolic disease》2003,26(7):617-627
Fabry disease is an X-linked glycosphingolipid storage disorder caused by a deficiency of alpha-galactosidase A. Affected patients experience debilitating neuropathic pain and have premature mortality due to renal failure, cardiovascular disease or cerebrovascular complications. The disease may be X-linked dominant, since most females heterozygous for Fabry disease are affected clinically. We evaluated the safety, efficacy and pharmacokinetics of agalsidase alfa (Replagal) administered intravenously to female patients with Fabry disease in an open-label, single-centre study. Fifteen severely affected patients received agalsidase alfa at 0.2 mg/kg every other week for up to 55 weeks. Agalsidase alfa was safe and well-tolerated in female patients. None of the patients developed antibodies or experienced an infusion reaction to agalsidase alfa. The pharmacokinetic profile of agalsidase alfa in female patients is comparable to the pharmacokinetics of agalsidase alfa in male patients. Mean urine sediment and plasma Gb3 levels decreased from baseline at 13, 27 and 41 weeks. A significant decrease in left ventricular mass from baseline was seen at weeks 27 (p = 0.003) and 41 (p = 0.039), and a significant reduction in QRS durations was seen at week 27 (p = 0.007). Furthermore, there was a significant improvement in quality of life. Renal function did not deteriorate in these 15 female patients over the 13- to 41-week period of observation. We conclude that enzyme replacement therapy with agalsidase alfa was safe and effective in female patients heterozygous for Fabry disease. 相似文献
13.
BO Motayo PA Akinduti FA Adeyakinu PO Okerentugba JC Nwanze CC Onoh HC Innocent-Adiele IO Okonko 《African health sciences》2013,13(4):1091-1097
Background
The increased reports of ESBL dissemination from various centres in south western, Nigeria and the recent emergence of carbapenem resistant bacteria prompted the conception of this study.Objectives
To demonstrate the relationship between high molecular weight plasmids and the expression of antibiotic multi-resistance including ESBL and carbapenemase.Methods
We investigated 97 isolates of selected organisms consisting of 67 E. coli and 30 Klebseilla spp for the presence of plasmids expressing ESBL including carbapenem-hydrolysing enzymes. Beta-lactamase was determined using acidometric method, while ESBL and carbapenemase activity was determined using the double-disk diffusion test as well as the Modified Hodge test (MHT). Plasmid profiles of ESBL and carbapenemase positive isolates were determined according to standard protocols.Results
An ESBL prevalence rate of 21.6% and carbapenem- resistance rate of 9.3% was recorded. Antibiotic susceptibility profile of ESBL isolates showed 100.0% resistance against Amoxicillin, Cotrimoxazole and Erythromycin. Moderate susceptibility was recorded against the Quinolone class of antibiotics; Meropenem remained the most active antibiotic against ESBL isolates with 62.5% against E. coli and 60% against K. pneumoniae. The plasmid profiles of our study isolates ranged from 11.8kbp to 35.5kbp.Conclusion
Due to the relationship between high molecular weight plasmids and multi-drug resistance, we hereby recommend regular molecular surveillance of this form in our study setting. 相似文献14.
目的:探讨双切口套法预防开放性胃肠手术后切口感染的临床效果。方法选取2013年3月~2014年8月在本院实施开放性胃肠手术的75例患者作为研究对象,随机分为观察组(38例)和对照组(37例)。观察组在开放性胃肠手术中采用双切口套法,对照组术中不使用任何切口保护套。比较两组的手术时间、术后首次排气时间、首次排便时间、住院时间及切口感染率。结果两组的手术时间比较,差异无统计学意义(P>0.05)。观察组的术后首次排气时间、首次排便时间及住院时间显著短于对照组,差异有统计学意义(P<0.05)。观察组的切口感染率为2.63%,显著低于对照组的16.22%,差异有统计学意义(P<0.05)。结论双切口套法可以明显降低开放性胃肠手术后的切口感染率,提高临床疗效。 相似文献
15.
16.
17.
Matthias Christgen MD PhD Oleg Gluz MD Nadia Harbeck MD Ronald E. Kates PhD Mieke Raap MD Henriette Christgen Michael Clemens MD Wolfram Malter MD Benno Nuding MD Bahriye Aktas MD Sherko Kuemmel MD Toralf Reimer MD Andrea Stefek MD Petra Krabisch MD Marianne Just MD Doris Augustin MD Monika Graeser MD Frederick Baehner MD Rachel Wuerstlein MD Ulrike Nitz MD Hans Kreipe MD the West German Study Group PlanB Investigators 《Cancer》2020,126(22):4847-4858
18.
32例国产人工髋关节翻修手术的临床体会 总被引:5,自引:3,他引:5
目的:探讨国产人工髋关节翻修原因。方法:回顾总结32例人工髋关节翻修中发现的问题,分析翻修原因。结果:32例中术前诊断松动16例,脱位4例,深部感染2例,白磨通3例,断柄2例,髋周及股部疼痛4例,股骨柄穿通皮质1例。26例取出假体顺利,6部部分骨长入珍珠面而取出假体困难。25例作全髋置换翻修,4例臼怀松动或位置不良致脱位仅翻修髋臼,1例股骨柄穿通皮质更换双动头,2例因深部感染严重而作单纯假体取出、清创术。全组病例经6个月-5年随访,Harris评分术前平均43分,术后平均81分,平均增加38分。结论:目前翻修病例仍以国产人工关节为主。翻修原因主要是:人工关节质量因素和手术技术因素。造成假体过早松动或种种其它并发症,最终失败。提示国产人工关节质量需改进,需相应配套器械,手术操作技术有待提高。 相似文献
19.
YENN‐JIANG LIN M.D. SHIH‐LIN CHANG M.D. LI‐WEI LO M.D. YU‐FENG HU M.D. KAZUYOSHI SUENARI M.D. CHENG‐HUNG LI M.D. TZE‐FAN CHAO M.D. FA‐PO CHUNG M.D. JO‐NAN LIAO M.D. BENY HARTONO M.D. HAN‐WEN TSO Ph.D. HSUAN‐MING TSAO M.D. JIN‐LONG HUANG M.D. TSAIR KAO Ph.D. SHIH‐ANN CHEN M.D. 《Journal of cardiovascular electrophysiology》2012,23(11):1155-1162
Modified Pulmonary Vein Isolation in AF Ablation. Introduction: Pulmonary vein isolation (PVI) is the primary ablation therapy in patients with atrial fibrillation (AF). We hypothesized that high dominant frequency (DF) sites (AF nests during sinus rhythm [SR]) adjacent to the PV ostia are associated with the atrial substrate that maintains AF, and PVI incorporating the high‐frequency AF nests may have a higher efficacy. Methods and Results: In a prospective and randomized comparison, 126 symptomatic paroxysmal AF patients that underwent PVI were enrolled. We compared the efficacy of a modified PVI (ablation line: 1.0–1.5 cm from the PV ostium with encircling the AF nests [spectral analysis with DF >70 Hz during SR, Group II]) versus the anatomy‐guided conventional PVI (Group I). In Group II, the DF value along the PV ostium was lower than 70 Hz after the PVI. The primary endpoint was the freedom from symptomatic atrial arrhythmias after a single procedure. We also followed the autonomic function by a time‐domain analysis of the heart rate variability. In both groups, AF nests were observed and electric isolation was successfully obtained in all patients. With a mean duration of 16 ± 6.1 months of follow‐up, Group II had a higher single procedure efficacy without drugs (78.7% vs 66.1%, log‐rank test: P = 0.02), and fewer repeat procedures (6.6% vs 23%; P = 0.04), as compared to Group I. Conclusion: PVI incorporating the high frequency AF nests adjacent to the PV ostia had a better single procedure efficacy. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1155–1162, November 2012) 相似文献
20.